People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

What the Trained Eye Cannot See: Detecting Movement Defects in Early ... in Parkinson's symptoms over ... Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28 ...

According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The class’ availability online through Zoom is a major feature. With how Parkinson’s can affect movement, and the ability to travel not always guaranteed, having access to pivotal information ...

Brigham Young University researchers are leading a significant validation study of a blood test designed to detect ...

What the Trained Eye Cannot See: Detecting Movement Defects in Early Stage Parkinson's Disease Aug ... proteins of Alzheimer's disease, are detected in blood once symptoms have started in Lewy's ...